HTG Molecular Diagnostics Inc
F:65H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HTG Molecular Diagnostics Inc
F:65H
|
US |
|
K
|
Kopin Corp
F:KOC
|
US |
|
E
|
Encavis AG
DUS:ECV
|
DE |
|
M
|
Medcaw Investments PLC
F:U09
|
UK |
|
Suncorp Group Ltd
F:SU40
|
AU |
|
G
|
Guangshen Railway Co Ltd
F:GRCH
|
CN |
|
Scully Royalty Ltd
F:MB01
|
HK |
|
N
|
NGK Insulators Ltd
XMUN:NGI
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 65H's stock price target?
Not Available
65H does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for HTG Molecular Diagnostics Inc?
Projected CAGR
56%
Over the last 1 year, the compound annual growth rate for Revenue has been -29%. The projected CAGR for the next 2 years is 56%.
What is the Gross Profit forecast for HTG Molecular Diagnostics Inc?
Projected CAGR
184%
Over the last 1 year, the compound annual growth rate for Gross Profit has been -63%. The projected CAGR for the next 1 year is 184%.